Kate Bingham is Managing Partner of SV Health Investors and the former Chair of the UK Vaccine Taskforce. As Chair of the Vaccine Taskforce in 2020, she led a team of world-class experts from across industry, science, academia, funding, regulators, logistics and government with the shared purpose of procuring and manufacturing COVID-19 vaccine/s as rapidly as possible. Kate will be joining Professor Sir Simon Wessely, RSM immediate Past-President, for a conversation about her career, the strategy and strive behind the UK’s historical COVID-19 vaccine effort, and how the pandemic has changed the biotech and pharmaceutical sector and public opinion.
In May 2020, Kate was appointed Chair of the UK Vaccine Taskforce reporting to the Prime Minster to lead UK efforts to find and manufacture a COVID-19 vaccine on a six-month engagement, stepping down as Chair in December 2020. On December 8 2020 the UK started COVID-19 vaccinations - the first Western country to do so. The Vaccine Taskforce helped place the UK at the leading edge of the international effort to fight the pandemic through the development of clinically safe and effective vaccines.
Kate has worked in the biotech and life sciences sectors for 30 years and is Managing Partner at SV Health Investors and a board member of the Francis Crick Institute. Her investments have led to the launch of six drugs for the treatment of patients with inflammatory and autoimmune disease and cancer.
Now more than ever, we need your help to continue our work. Please consider making a donation for watching this free webinar.
Thank you for your generosity. www.rsm.ac/donate
Join in the conversation online by using #RSMLive
Follow us on Twitter: @RoySocMed
*This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
**All views expressed in this webinar are of the speakers themselves and not of the RSM.